NASDAQ$LFMD
LifeMD Inc · Q2 2025 earnings
Q2 2025 earnings · · After market close · Investor relations
Briefing
LifeMD Inc reported Q2 2025 revenue of $62.2 million, up 23% year-over-year, with a narrowed net loss.
LifeMD achieved $62.2 million in quarterly revenue driven by 30% growth in telehealth subscriptions, primarily from its primary care and weight management programs. Gross profit rose to $54.8 million while operating loss improved to $0.9 million. The company maintained positive operating cash flow trends and ended the quarter with $36.2 million in cash.
- Telehealth revenue grew 30% to $48.6 million, led by subscription growth in primary care and weight management.
- Gross margin remained strong at 88% despite higher fulfillment and physician costs.
- Net loss narrowed to $1.6 million from $6.8 million in the prior-year quarter.
- Cash position strengthened to $36.2 million with $11.7 million in operating cash flow for the first half.
Headline financials
Revenue & EPS history
LifeMD · Revenue · Quarterly
$62.2M
Revenue by segment
LifeMD · $62.2M total across 2 segments · Q2 2025
- Telehealth$48.6M—78.1%
- WorkSimpli$13.7M—21.9%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports
+2.3%
Avg return
Earnings day
+8.3%
Avg return
5 days after
+5.9%
Avg return
30 days after
48%
27 / 56 earnings
Positive
+39.3%
Q1 2013
Best reaction
-40.0%
Q3 2014
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2025 | — | — | — | |
| Q1 2026 | +2.7% | -14.2% | -4.9% | |
| Q4 2025 | +25.3% | +27.6% | +9.0% | |
| Q3 2025 | -13.6% | -18.6% | -31.5% | |
| Q1 2025 | +3.6% | +10.2% | +63.9% | |
| Q4 2024 | +30.7% | +39.1% | +16.6% | |
| Q3 2024 | +15.6% | +41.5% | +10.3% | |
| Q2 2024 | -9.8% | -5.7% | -17.3% | |
| Q1 2024 | -24.9% | -23.0% | -39.1% | |
| Q4 2023 | +4.8% | +26.0% | +23.2% | |
| Q3 2023 | -5.4% | -1.4% | +16.5% | |
| Q2 2023 | +16.8% | +16.0% | +16.5% | |
| Q1 2023 | -3.8% | +2.2% | +36.1% | |
| Q4 2022 | +23.9% | +23.9% | +45.3% | |
| Q3 2022 | +23.4% | +22.9% | +23.4% | |
| Q2 2022 | -1.0% | -6.8% | -12.3% | |
| Q1 2022 | +2.6% | +9.8% | +22.2% | |
| Q4 2021 | +1.2% | +2.8% | +11.8% | |
| Q3 2021 | -4.0% | -11.0% | -13.9% | |
| Q2 2021 | -14.9% | -21.7% | -17.5% | |
| Q1 2021 | +27.6% | +28.8% | +95.6% | |
| Q4 2020 | -16.9% | -11.9% | +3.6% | |
| Q3 2020 | +12.7% | +67.4% | +39.5% | |
| Q2 2020 | -5.7% | -16.0% | -28.6% | |
| Q1 2020 | +3.1% | -3.1% | -3.1% | |
| Q4 2019 | -4.5% | -4.5% | +27.3% | |
| Q3 2019 | +0.0% | +11.8% | -17.6% | |
| Q2 2019 | +0.0% | +15.4% | +7.7% | |
| Q1 2019 | +13.3% | +13.3% | -20.0% | |
| Q4 2018 | +6.7% | +13.3% | +0.0% | |
| Q3 2018 | +0.0% | -19.0% | -19.0% | |
| Q2 2018 | -7.4% | -3.7% | -7.4% | |
| Q1 2018 | -4.0% | -4.0% | -24.0% | |
| Q4 2017 | -7.1% | +7.1% | -7.1% | |
| Q3 2017 | +4.8% | +4.8% | +7.1% | |
| Q1 2017 | +9.7% | +45.2% | +22.6% | |
| Q2 2017 | +9.7% | +45.2% | +22.6% | |
| Q4 2016 | +8.1% | +8.1% | -18.9% | |
| Q3 2016 | -3.8% | +15.4% | -11.5% | |
| Q2 2016 | +0.0% | -8.0% | +4.0% | |
| Q1 2016 | +15.4% | — | — | |
| Q4 2015 | +11.1% | — | — | |
| Q3 2015 | +0.0% | — | — | |
| Q2 2015 | +30.0% | — | — | |
| Q1 2015 | -33.3% | — | — | |
| Q4 2014 | +0.0% | — | — | |
| Q3 2014 | -40.0% | — | — | |
| Q2 2014 | -25.0% | — | — | |
| Q1 2014 | +17.6% | — | — | |
| Q4 2013 | +4.2% | — | — | |
| Q3 2013 | +8.0% | — | — | |
| Q2 2013 | -10.0% | — | — | |
| Q1 2013 | +39.3% | — | — | |
| Q4 2012 | -7.7% | — | — | |
| Q3 2012 | +0.0% | — | — | |
| Q2 2012 | +0.0% | — | — | |
| Q1 2012 | +0.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro